Avishkar Diagnostics (W.B.) Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
as on 26-12-2024
- Paid Up Capital ₹ 0.25 M
as on 26-12-2024
- Company Age 1 Year 1 Day
- Last Filing with ROC 31 Mar 2024
About Avishkar Diagnostics (W.B.)
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 0.25 M, as per Ministry of Corporate Affairs (MCA) records.
Sunaina Bihani, Siddarth Daga, Rakesh, and Two other members serve as directors at the Company.
- CIN/LLPIN
U86905WB2024PTC267844
- Company No.
267844
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
23 Jan 2024
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Company Details
- Location
Bardhaman, West Bengal, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Avishkar Diagnostics (W.B.)?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rakesh  | Managing Director | 23-Jan-2024 | Current |
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sunaina Bihani | Nominee Director | 22-May-2024 | Current |
| Siddarth Daga | Nominee Director | 22-May-2024 | Current |
| Neetu Singh | Director | 23-Jan-2024 | Current |
| Aishwarya Sundeep | Nominee Director | 22-May-2024 | Current |
Financial Performance of Avishkar Diagnostics (W.B.).
Enhance accessibility to Avishkar Diagnostics (W.B.)'s financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Avishkar Diagnostics (W.B.)?
Unlock access to Avishkar Diagnostics (W.B.)'s control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Victoria Mri Centre Private LimitedActive 17 years 9 daysSunaina Bihani and Siddarth Daga are mutual person
Vins Bioproducts LimitedActive 27 years 11 monthsSunaina Bihani and Siddarth Daga are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Avishkar Diagnostics (W.B.)?
Avishkar Diagnostics (W.B.) has a workforce of 0 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Avishkar Diagnostics (W.B.), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Avishkar Diagnostics (W.B.)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.